Global Respiratory Marketing Lead/Raleigh

UCBRaleigh, NC
16h$184,000 - $241,000Hybrid

About The Position

We are looking for a Global Marketing Lead who is strategic, collaborative, and innovative to join us in our Stakeholder Integration team, based in one of the following UCB offices the US : Atlanta, Raleigh or Boston or our Brussels office in Belgium. (This is not a remote role relocation packages may possibly be provided) About the role You will be leading global cross-functional partnerships to maximize the potential of a mid-stage immunology asset across Respiratory indications. Your role will involve developing insight and expertise into the respiratory disease landscape, stakeholders and patients to shape stage-appropriate marketing and commercial decisions.

Requirements

  • Bachelor’s degree.
  • Minimum of 10+ years in pharmaceutical strategy & leadership.
  • Minimum of 2+ years Must have experience in Respiratory asset development for mid-stage and/or pre-launch brands.
  • Minimum of 3+ years in US commercial role within respiratory therapeutic area.
  • Minimum of 3+ years in strategic marketing and/or planning role, global marketing, leading product launches, driving brand growth, lifecycle planning, strategic consulting etc.
  • Ability to travel domestically and internationally up to 30%

Nice To Haves

  • Experience in the EU within commercial role within respiratory therapeutic area.
  • Good understanding of market access challenges for high-cost medicines.
  • Strong business acumen, analytical skills, and the ability to synthesize complex information into actionable strategies.

Responsibilities

  • Develop a deep understanding and knowledge base across Respiratory indications, including COPD, Bronchiectasis and Asthma
  • Develop strategic imperatives for proof-of-concept (Phase 2 & 3 clinical development) Ph2b & Ph3 programs to shape global strategy and associated tactics.
  • Contribute to the Global Strategic Asset Plan (GSAP) focusing on maximizing outcomes/investment ratio. Linking strategic choices with development indications in other therapeutic areas
  • Lead the patient population-indication value proposition, strategy, and positioning short/long term.
  • Act as an integral member of the asset stakeholder integration community.
  • Recommend indication level clinical data and evidence for differentiation.
  • Build a learning journey to baseline company knowledge in respiratory diseases.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service